LMR Partners’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48K Hold
400,000
﹤0.01% 1311
2025
Q4
$124K Hold
400,000
﹤0.01% 1325
2025
Q3
$116K Hold
400,000
﹤0.01% 1270
2025
Q2
$100K Hold
400,000
﹤0.01% 1175
2025
Q1
$80K Buy
+400,000
New +$70.4K ﹤0.01% 1165

Other funds holding TDACW

LMR Partners's TDACW Position: Q1 2026 in Review

LMR Partners held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 400,000 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

LMR Partners first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $124K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • LMR Partners held 400,000 shares of Translational Development Acquisition Corp Warrants worth $48K as of Q1 2026.
  • LMR Partners left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1311 holding.
  • LMR Partners first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
  • LMR Partners's Translational Development Acquisition Corp Warrants position peaked at $124K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.